To examine whether the enhanced MMP9 activity in the peri-infarct region might affect the integrity of BBB, we measured the expression of tight-junction protein occludin in this region using immunofluorescence staining at 14 days after stroke. The gene discussed is OCLN; the disease is Stroke.